Metastatic renal cell cancer treatments: An indirect comparison meta-analysis

BACKGROUND: Treatment for metastatic renal cell cancer (mRCC) has advanced dramatically with understanding of the pathogenesis of the disease. New treatment options may provide improved progression-free survival (PFS). We aimed to determine the relative effectiveness of new therapies in this field....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mills, Edward J, Rachlis, Beth, O'Regan, Chris, Thabane, Lehana, Perri, Dan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2009
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2637892/
https://ncbi.nlm.nih.gov/pubmed/19173737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-34
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak